Dr..PANKAJ RANJAN

Dr. ANURAG NARULA, Dr.RAJIV KUMAR, Dr.AMAN GAUR

Abstract

Materials and Methods:

Topical Cyclosporine 0.1 % was used in the study.Main outcome measures were degree of intraocular inflammation, visual acuity and dose reduction of steroids.

Results:

Intraocular inflammation was improved or stable in 90% of patients, visual acuity was improved or stable in 85%, and steroid dosage was reduced in 77% (by half or more in 63%). Adverse symptoms was mainly one burning sensation/irritation in 90% of cases.

Conclusions:

Cyclosporine was found to be effective in reducing inflammation and protecting vision in uveitis.